Open access
Jul 2026
SYNGR2 as a Multifaceted Biomarker in Hepatocellular Carcinoma Linking Prognosis, Immune Microenvironment and Therapeutic Response
SYNGR2 has emerged as a multifaceted biomarker candidate in HCC, associated with prognosis, an immunosuppressive microenvironment, and differential therapeutic responses, and its integration into clinical models could enhance prognostic stratification and guide personalized treatment strategies.
Rong Wang, Dongmei Chen, Qiu Du et al.
· Technology in Cancer Researc... · 0 citations